Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

A Parallel Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Advanced or Metastatic Non-Small Cell Lung Cancer (MRTX-500)

  • Details

ClinicalTrials.gov ID: NCT02954991
Diagnosis Type: Lung Cancer
USOR Number: 17039

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Woodbury

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients withMetastatic Castration-resistant Prostate Cancer Associated withHomologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: Prostate Cancer
USOR Number: 16238

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, MN 55125
P: (651) 735-7414

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Saint Paul

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients withMetastatic Castration-resistant Prostate Cancer Associated withHomologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: Prostate Cancer
USOR Number: 16238

  • Practice Details

310 Smith Ave N
Suite 100
Saint Paul, MN 55102
P: (651) 251-5500

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Maplewood

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients withMetastatic Castration-resistant Prostate Cancer Associated withHomologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: Prostate Cancer
USOR Number: 16238

  • Practice Details

1580 Beam Avenue
Maplewood, MN 55109
P: (651) 779-7978

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Minneapolis

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients withMetastatic Castration-resistant Prostate Cancer Associated withHomologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: Prostate Cancer
USOR Number: 16238

  • Practice Details

910 E 26th St, Suite 200
Minneapolis, MN 55404
P: (612) 884-6300

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Edina

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients withMetastatic Castration-resistant Prostate Cancer Associated withHomologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: Prostate Cancer
USOR Number: 16238

  • Practice Details

6545 France Avenue, Suite 210
Edina, MN 55435
P: (952) 928-2900

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Minnesota Oncology - Coon Rapids

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients withMetastatic Castration-resistant Prostate Cancer Associated withHomologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: Prostate Cancer
USOR Number: 16238

  • Practice Details

11850 Blackfoot St NW, Suite 100
Coon Rapids, MN 55433
P: (763) 712-2100

More Details View Practice Page

Lymphomas

Clinical Trial at: Minnesota Oncology - Woodbury

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Lymphomas
USOR Number: 11282

  • Practice Details

6025 Lake Rd, Suite 110
Woodbury, MN 55125
P: (651) 735-7414

More Details View Practice Page

Lymphomas

Clinical Trial at: Minnesota Oncology - Saint Paul

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Lymphomas
USOR Number: 11282

  • Practice Details

310 Smith Ave N
Suite 100
Saint Paul, MN 55102
P: (651) 251-5500

More Details View Practice Page

Lymphomas

Clinical Trial at: Minnesota Oncology - Maplewood

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Lymphomas
USOR Number: 11282

  • Practice Details

1580 Beam Avenue
Maplewood, MN 55109
P: (651) 779-7978

More Details View Practice Page
1 … 12 13 14 15

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.